Wigard Kloosterman

Wigard Kloosterman

Company: Frame Therapeutics

Job title: Chief Scientific Officer Frame


Identification of Frame Neoantigens to Develop Highly Immunogenic Cancer Vaccines 2:00 pm

Identifying Frame neoantigens derived from neo-open reading frames in human cancers identification of all neoantigens resulting from SVs and subsequent RNA splicing Utilising a unique combination of tumour sequencing technologies for comprehensive detection of neoantigens at high sensitivity Demonstrating pre-clinical proof of the overwhelming immunogenicity of Frame neoantigensRead more

day: Track A - Day 1 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.